These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 26544762

  • 1. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
    Crans DC.
    J Org Chem; 2015 Dec 18; 80(24):11899-915. PubMed ID: 26544762
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluating transition state structures of vanadium-phosphatase protein complexes using shape analysis.
    Sánchez-Lombardo I, Alvarez S, McLauchlan CC, Crans DC.
    J Inorg Biochem; 2015 Jun 18; 147():153-64. PubMed ID: 25953100
    [Abstract] [Full Text] [Related]

  • 5. The trigonal-bipyramidal NO4 ligand set in biologically relevant vanadium compounds and their inorganic models.
    Rehder D.
    J Inorg Biochem; 2008 Jun 18; 102(5-6):1152-8. PubMed ID: 18255153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M, Henao F, Tiago T, Duarte RO, Moura JJ, Baruah B, Crans DC.
    Inorg Chem; 2008 Jul 07; 47(13):5677-84. PubMed ID: 18510311
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of phosphate-metabolizing enzymes by oxovanadium(V) complexes.
    Stankiewicz PJ, Tracey AS, Crans DC.
    Met Ions Biol Syst; 1995 Jul 07; 31():287-324. PubMed ID: 8564811
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae in vitro.
    Turner TL, Nguyen VH, McLauchlan CC, Dymon Z, Dorsey BM, Hooker JD, Jones MA.
    J Inorg Biochem; 2012 Mar 07; 108():96-104. PubMed ID: 22005446
    [Abstract] [Full Text] [Related]

  • 11. Vanadium Compounds with Antidiabetic Potential.
    Amaral LMPF, Moniz T, Silva AMN, Rangel M.
    Int J Mol Sci; 2023 Oct 27; 24(21):. PubMed ID: 37958659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.
    Crans DC, Mahroof-Tahir M, Keramidas AD.
    Mol Cell Biochem; 2023 Oct 27; 153(1-2):17-24. PubMed ID: 8927035
    [Abstract] [Full Text] [Related]

  • 15. Vanadium(V) complexes in enzyme systems: aqueous chemistry, inhibition and molecular modeling in inhibitor design.
    Bhattacharyya S, Tracey AS.
    J Inorg Biochem; 2001 May 27; 85(1):9-13. PubMed ID: 11377690
    [Abstract] [Full Text] [Related]

  • 16. Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review.
    Scior T, Guevara-García A, Bernard P, Do QT, Domeyer D, Laufer S.
    Mini Rev Med Chem; 2005 Nov 27; 5(11):995-1008. PubMed ID: 16307529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemistry, urease inhibition, and phytotoxic studies of binuclear vanadium(IV) complexes.
    Ara R, Ashiq U, Mahroof-Tahir M, Maqsood ZT, Khan KM, Lodhi MA, Choudhary MI.
    Chem Biodivers; 2007 Jan 27; 4(1):58-71. PubMed ID: 17256735
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.